NCCN Cytogenetic Risk Group for ALL

**Semantic type:** Intellectual Product

**Definition:** A classification strategy for Acute Lymphoblastic Leukemia (ALL) developed by NCCN that stratifies risk groups based on the cytogenetic and molecular features of ALL. (NCCN Guidelines, Version 1.2020, February 20, 2020)